Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial - Highland, K B; Distler, O; Kuwana, M (Lancet Respir Med, 2021)